Celularity Inc

詳細情報 Celularity Inc 企業名

Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs that target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Interfyl and Rebound products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).

企業情報

企業コードCELUW

会社名Celularity Inc

上場日May 23, 2019

最高経営責任者「CEO」Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

従業員数- -

証券種類Company Warrant

決算期末- -

本社所在地170 Park Ave

都市FLORHAM PARK

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号07932

電話番号19087682170

ウェブサイトhttps://celularity.com/

企業コードCELUW

上場日May 23, 2019

最高経営責任者「CEO」Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Joseph Dossantos

Interim Chief Financial Officer

--

Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.

Independent Director

--

Dr. Peter H. Diamandis, M.D.

Independent Director

--

Mr. John R. Haines

Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary

--

Mr. Stephen A. Brigido

President - Degenerative Disease

--

Ms. Diane L. Parks

Independent Director

--

Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

Chairman of the Board, Chief Executive Officer

--

Mr. Carlos Ramirez

Senior Vice President - Investor Relations

--

Mr. Vincent Levien

Director

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Joseph Dossantos

Interim Chief Financial Officer

--

Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.

Independent Director

--

Dr. Peter H. Diamandis, M.D.

Independent Director

--

Mr. John R. Haines

Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary

--

Mr. Stephen A. Brigido

President - Degenerative Disease

--

Ms. Diane L. Parks

Independent Director

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Fri, Aug 15

株主統計

種類

株主統計

比率

他の

100.00%

株主統計

比率

他の

100.00%

種類

株主統計

比率

他の

100.00%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

27

2.48M

0.00%

-1.91M

2025Q1

31

2.48M

0.00%

-2.12M

2024Q4

30

2.60M

0.00%

-2.17M

2024Q3

31

2.80M

0.00%

-1.78M

2024Q2

32

2.67M

0.00%

-2.18M

2024Q1

32

2.68M

0.00%

-2.18M

2023Q4

31

3.99M

0.00%

-892.77K

2023Q3

31

4.57M

0.00%

-1.21M

2023Q2

29

5.51M

0.00%

-1.17M

2023Q1

26

6.63M

0.00%

-928.95K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Walleye Capital LLC

850.11K

0%

-86.66K

-9.25%

Mar 31, 2025

Linden Advisors L.P.

550.12K

0%

--

Mar 31, 2025

Healthcare Of Ontario Pension Plan

350.00K

0%

--

Mar 31, 2025

Peak6 Capital Management LLC

171.36K

0%

--

Mar 31, 2025

Davidson Kempner Capital Management LP

150.80K

0%

--

Mar 31, 2025

Context Capital Management LLC

150.00K

0%

--

Mar 31, 2025

Corient Private Wealth LLC

55.00K

0%

--

Mar 31, 2025

EMFO, LLC

50.00K

0%

--

Jun 30, 2024

Clear Street LLC

11.91K

0%

-200.00

-1.65%

Mar 31, 2025

Weaver Capital Management LLC

11.31K

0%

--

Mar 31, 2025

詳細を見る

0.045USD

Celularity Inc

0.045

概要

企業名

金融

分析